TI
HRMY icon

Trexquant Investment’s Harmony Biosciences HRMY Stock Holding History

Trexquant Investment’s Portfolio HRMY Stock Details HRMY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$6.36M Sell
174,700
-420,150
-71% -$13.3M 0.04% 617
2026
Q1 		$16.7M Buy
594,850
+295,446
+99% +$9.69M 0.12% 202
2025
Q4 		$11.2M Buy
299,404
+27,433
+10% +$902K 0.1% 274
2025
Q3 		$7.5M Buy
271,971
+167,533
+160% +$5.77M 0.08% 395
2025
Q2 		$3.3M Sell
104,438
-9,290
-8% -$299K 0.04% 701
2025
Q1 		$3.77M Sell
113,728
-61,846
-35% -$2.22M 0.04% 617
2024
Q4 		$6.04M Buy
+175,574
New +$6.03M 0.07% 454
2023
Q3 		– Sell
-57,468
Closed -$2.02M – 1611
2023
Q2 		$2.02M Buy
57,468
+42,259
+278% +$1.46M 0.05% 488
2023
Q1 		$497K Sell
15,209
-18,052
-54% -$822K 0.01% 1005
2022
Q4 		$1.83M Buy
33,261
+24,047
+261% +$1.32M 0.05% 432
2022
Q3 		$408K Sell
9,214
-6,344
-41% -$309K 0.01% 893
2022
Q2 		$759K Buy
15,558
+530
+4% +$23.9K 0.03% 633
2022
Q1 		$731K Buy
15,028
+354
+2% +$14.4K 0.03% 606
2021
Q4 		$626K Sell
14,674
-5,786
-28% -$231K 0.04% 551
2021
Q3 		$784K Buy
20,460
+9,272
+83% +$299K 0.06% 385
2021
Q2 		$316K Buy
+11,188
New +$336K 0.03% 687

Other funds holding HRMY

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
American Century Companies
American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
LSV Asset Management
LSV Asset Management Chicago, Illinois $55.1B AUM 45.38% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
AC
Armistice Capital New York $8.17B AUM 68.82% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Trexquant Investment's HRMY Position: Q2 2026 in Review

Trexquant Investment reduced its Harmony Biosciences (HRMY) stake by 71% in Q2 2026, selling an estimated $13.3M and leaving 174,700 shares worth $6.36M. The position accounts for 0.04% of the portfolio, ranked #617.

Trexquant Investment first reported a position in HRMY in Q2 2021 and has held it in 16 quarters since. The position peaked at $16.7M in Q1 2026. 327 funds tracked by Wall St. Rank hold HRMY as of Q2 2026.

  • Trexquant Investment held 174,700 shares of Harmony Biosciences worth $6.36M as of Q2 2026.
  • Trexquant Investment sold 420,150 Harmony Biosciences shares in Q2 2026, an estimated $13.3M.
  • Harmony Biosciences made up 0.04% of Trexquant Investment's portfolio in Q2 2026, its #617 holding.
  • Trexquant Investment first reported a position in Harmony Biosciences in Q2 2021 and has held it in 16 quarters since.
  • Trexquant Investment's Harmony Biosciences position peaked at $16.7M in Q1 2026.
  • 327 funds tracked by Wall St. Rank held Harmony Biosciences as of Q2 2026.

Based on Trexquant Investment's 13F filing for Q2 2026, filed 14 Aug 2026.